脂毒性驱动的代谢功能障碍相关的脂肪性肝病 (MASLD)
Santiago Iturbe-Rey1, Claudia Maccali2, Marco Arrese3
1Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Donostia-San Sebastian, Spain.
Atherosclerosis
|November 24, 2024
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及有毒脂质的积累,导致肝损伤. 这篇评论探讨了脂毒性.
科学领域:
- 肝病学和代谢疾病
- 肝脏损伤的分子机制
背景情况:
- 与代谢功能障碍相关的脂肪酸性肝病 (MASLD) 影响了超过三分之一的人口,从脂肪酸症发展为肝硬化.
- MASLD是导致肝衰竭,癌症和死亡的主要危险因素.
- 病原发生涉及代谢,环境,微生物和遗传因素.
研究的目的:
- 综合审查脂毒性在MASLD病变发生中的作用.
- 讨论关键的脂类物种,分子机制和细胞特异性影响.
- 突出针对脂毒性和脂质代谢的潜在治疗策略.
主要方法:
- 对MASLD的脂质毒性研究的文献综述.
- 脂类物种,分子通路和细胞反应的分析.
- 评估新出现的治疗目标.
主要成果:
- 不调节的脂质组成产生有毒物种,诱导脂毒性和细胞应激.
- 脂毒性激活细胞死亡途径,导致炎症,纤维化和致癌.
- 特定的脂类物种及其代谢途径是MASLD进展的关键驱动因素.
结论:
- 脂毒性是MASLD发病的一个核心机制,驱动肝损伤和进展.
- 了解细胞特异性脂毒性作用对于向治疗至关重要.
- 调节脂毒性和脂质代谢为MASLD提供了有前途的治疗途径.
更多相关视频
相关概念视频
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Liver Physiology
441
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
441
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
536
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
536
Lipid Catabolism
1
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1
Necrosis
4.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K


